Meryl Streep and the problems of clinical trials

por Isenberg, David A
Publicado 2012

Life-Threatening Complications of Biological Therapies

por Campar, Ana, Isenberg, David A.
Publicado 2011

“Mixed connective tissue disease”: a condition in search of an identity

por Alves, Marta R., Isenberg, David A.
Publicado 2020

Towards Precision Medicine in Systemic Lupus Erythematosus

por Lever, Elliott, Alves, Marta R, Isenberg, David A
Publicado 2020

Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?

por Lorenzo-Vizcaya, Ana, Fasano, Serena, Isenberg, David A
Publicado 2020

Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities

por Neves, Ana, Viveiros, Luísa, Venturelli, Veronica, Isenberg, David A
Publicado 2023

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study

por Urowitz, Murray B, Isenberg, David A, Wallace, Daniel J
Publicado 2015

Belimumab in systemic lupus erythematosus

por Vilas-Boas, Andreia, Morais, Sandra A, Isenberg, David A
Publicado 2015

Very delayed lupus nephritis: a report of three cases and literature review

por Alexandre, André R, Carreira, Pedro L, Isenberg, David A
Publicado 2018

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up

por Luo, Weike, Farinha, Filipa, Isenberg, David A, Rahman, Anisur
Publicado 2022

A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus

por Menon, Madhvi, Blair, Paul A., Isenberg, David A., Mauri, Claudia
Publicado 2016

Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders

por Isenberg, David A., Kao, Amy H., Aydemir, Aida, Merrill, Joan T.
Publicado 2020

How COVID-19 is changing rheumatology clinical practice

por Bonfá, Eloisa, Gossec, Laure, Isenberg, David A., Li, Zhanguo, Raychaudhuri, Soumya
Publicado 2020

Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long‐Term Effects on Serum Immunoglobulins

por Reddy, Venkat, Martinez, Lina, Isenberg, David A., Leandro, Maria J., Cambridge, Geraldine
Publicado 2017

Can we predict if patients with SLE will require more than one cycle of rituximab?

por Fernández González, Raquel, Abida, Rym, Gisca, Eugeniu, Duarte, Leila, Isenberg, David A
Publicado 2021

Lipid-Antigen Presentation by CD1d(+) B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells

por Bosma, Anneleen, Abdel-Gadir, Azza, Isenberg, David A., Jury, Elizabeth C., Mauri, Claudia
Publicado 2012

Impact of pre-transplant time on dialysis on survival in patients with lupus nephritis

por Ntatsaki, Eleana, Velo-Garcia, Alba, Vassiliou, Vassilios S., Salama, Alan D., Isenberg, David A.
Publicado 2018

B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?

por Mehta, Puja, Porter, Joanna C, Chambers, Rachel C, Isenberg, David A, Reddy, Venkat
Publicado 2020

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus

por Reddy, Venkat, Cambridge, Geraldine, Isenberg, David A., Glennie, Martin J., Cragg, Mark S., Leandro, Maria
Publicado 2015

52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block

por Fritsch, Christine, Hoebeke, Johan, Dali, Hayet, Ricchiuti, Vincent, Isenberg, David A, Meyer, Olivier, Muller, Sylviane
Publicado 2006